1. Home
  2. ADMA vs CEF Comparison

ADMA vs CEF Comparison

Compare ADMA & CEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • CEF
  • Stock Information
  • Founded
  • ADMA 2004
  • CEF N/A
  • Country
  • ADMA United States
  • CEF
  • Employees
  • ADMA N/A
  • CEF N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • CEF
  • Sector
  • ADMA Health Care
  • CEF
  • Exchange
  • ADMA Nasdaq
  • CEF NYSE
  • Market Cap
  • ADMA 4.1B
  • CEF 4.9B
  • IPO Year
  • ADMA N/A
  • CEF N/A
  • Fundamental
  • Price
  • ADMA $17.89
  • CEF $24.06
  • Analyst Decision
  • ADMA Strong Buy
  • CEF
  • Analyst Count
  • ADMA 4
  • CEF 0
  • Target Price
  • ADMA $21.25
  • CEF N/A
  • AVG Volume (30 Days)
  • ADMA 2.6M
  • CEF N/A
  • Earning Date
  • ADMA 02-26-2025
  • CEF N/A
  • Dividend Yield
  • ADMA N/A
  • CEF N/A
  • EPS Growth
  • ADMA N/A
  • CEF N/A
  • EPS
  • ADMA 0.28
  • CEF N/A
  • Revenue
  • ADMA $382,809,000.00
  • CEF N/A
  • Revenue This Year
  • ADMA $66.84
  • CEF N/A
  • Revenue Next Year
  • ADMA $14.72
  • CEF N/A
  • P/E Ratio
  • ADMA $63.82
  • CEF N/A
  • Revenue Growth
  • ADMA 63.39
  • CEF N/A
  • 52 Week Low
  • ADMA $4.37
  • CEF N/A
  • 52 Week High
  • ADMA $23.64
  • CEF N/A
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 42.39
  • CEF 44.22
  • Support Level
  • ADMA $17.08
  • CEF $23.86
  • Resistance Level
  • ADMA $18.97
  • CEF $24.11
  • Average True Range (ATR)
  • ADMA 0.75
  • CEF 0.23
  • MACD
  • ADMA -0.20
  • CEF -0.05
  • Stochastic Oscillator
  • ADMA 27.81
  • CEF 28.34

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About CEF SPROTT PHYSICAL GOLD AND SILVER TR

Sprott Physical Gold and Silver Trust is a closed end mutual fund trust. The trust invests and holds all of its assets in physical gold and silver bullion and seeks to provide a secure, convenient, and exchange-traded investment alternative for investors interested in holding physical bullion without the inconvenience that is typical of direct investment.

Share on Social Networks: